United States · Amendment · HAMDT
HAMDT 662 (114th)
An amendment numbered 7 printed in House Report 114-193 to direct the Food and Drug Administration to issue a report on the risks and benefits associated with a two-tiered approval process that would permit certain medical devices to provisionally come to market if they have demonstrated safety but not efficacy.
Introduced
—
Last action
—
Status
By unanimous consent, the Polis amendment was withdrawn. (consideration: CR H5078)
Sponsors
Rep. Polis, Jared [D-CO-2]
Subjects
Discovery layer
Source updated
3 February 2022
Records
Official amendment HAMDT 662 (114th) from United States at United States Congress. Status: By unanimous consent, the Polis amendment was withdrawn. (consideration: CR H5078).
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Sponsors
- Rep. Polis, Jared [D-CO-2] · D · Sponsor
Related records
- amends → 21st Century Cures Act
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/amendment/114th-congress/hamdt-662
- Open data entity: https://api.congress.gov/v3/amendment/114/hamdt/662
- us · 114-hamdt-662 · source updated 3 February 2022